
Urology Residency
College
- Center City Campus
- Sidney Kimmel Medical College
Degree Earned
- Residency
Program Length
5 years
Program Type
- On Campus
Leadership
Leadership
Leadership
Contact Us
1025 Walnut Street
College Building, Suite 1112
Philadelphia, PA 19107
The Jefferson Urology Residency Training Program is a five-year program that provides a well-rounded experience in all major disciplines of urology. Three residents are accepted each year through the AUA Match Program. Upon completion of the program, our trainees are equally well prepared to seek competitive fellowship training or enter private practice. The urology faculty consists of a core of general urologists and fellowship trained urologists who represent the full spectrum of urologic subspecialties.
Thomas Jefferson University, set in historic Philadelphia, has a strong tradition in urology. Sidney Kimmel Medical College was founded in 1824 (formerly known as Jefferson Medical College) and has more living physician graduates than any other medical school in the country. The Department of Urology was founded in 1904, making it one of the oldest formal departments of urology in the U.S. and the oldest on the East Coast. While many physicians were traditionally trained in “Genitourinary Surgery” in the early 1900s, the Urology Residency Training Program was formally established at Jefferson in 1946, by Dr. D. M. Davis, one of the well-known figures in modern urology. In 2004, we celebrated our centennial year with a variety of special events, including the dedication of the Jefferson Urology Museum.
Recent Department Peer-Reviewed Publications
Publications
- Artificial Intelligence Use in Medical Education: Best Practices and Future Directions
- Antibiotic prophylaxis prior to office-based urologic procedures: outcomes from a department-wide quality improvement project
- Port site metastasis after robotic assisted laparoscopic radical prostatectomy: Diagnosis via prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL PET/CT
- Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab
- Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles